An up-to-date catalog of available urinary biomarkers for the surveillance of non-muscle invasive bladder cancer.

Current commercially available urinary biomarker-based tests are not sufficiently validated to be widely used in clinical practice. Several novel biomarkers are currently under investigation. Prospective multicenter analyses will be needed to establish their clinical relevance and value.